Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...

Medra, a US company developing the first platform for physical AI scientists, has announced a $52 million Series A financing.

US late-stage rare disease focused pharma Rezolute announced disappointing top-line results from its Phase III sunRIZE study ...

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...

The European Medicines Agency has welcomed a political agreement between EU institutions on a far-reaching reform of ...

Irish pharma manufacturer Gaelic Laboratories has acquired Athlone Laboratories, another Irish producer focused on oral dose ...

California, USA-based biotech Prolynx, which is developing a next-generation portfolio of ultra-long-acting medicines for ...

The US Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of an oral pellet ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...

Eli Lilly has shown the strength of its obesity pipeline beyond its on-market blockbuster Mounjaro (tirzepatide) ...

US biotech Amgen (Nasdaq: AMGN) has won approval from the US regulator for Uplizna (inebilizumab-cdon) to treat adults with ...